← Back

UK Innovation & Science Seed Fund (UKI2S)

Europe HQ Pre-seed Seed
Latest fund: £150M · announced Jun 2026✓ Community-verified
Cheque range
up to £1.5M
Stages
Pre-seed, Seed
Avg deals / year
–
Leads rounds
No
HQ
Manchester, UK
Fund type
Venture fund
Last fund raised
2026-06 · £150M

01 · Thesis & focus

Evergreen, government-backed pre-seed+ fund managed by Future Planet Capital. It invests in UK science and public-sector research spinouts across deep tech, including fusion, space, defence & security, engineering biology, clean energy and healthcare. A June 2026 top-up of £33.25m (UKAEA £20m, UK Space Agency £9.25m, MoD £4m) raised total capacity to £150m, and the fund reports £55.7m deployed across 123 companies.

Sectors (5)

02 · Recent publicly announced deals

Silvia Bio 🇬🇧 Seed · Oct 2026 · $4M First-cheque stage announcement ↗

Sheffield startup profiling mammalian cells and developing precision media additives to raise biomanufacturing yields.

Founders: Adam B.
HydRegen 🇬🇧 Series A (first close) · Oct 2026 · $8M announcement ↗

Enzyme-based catalysts replacing precious-metal catalysts in chemical manufacturing

Founders: Holly R., Sarah P.
StandardX 🇬🇧 Seed · Sep 2026 First-cheque stage site ↗

Compact particle-accelerator platform producing medical, industrial and energy isotopes near the point of use. London.

Founders: Ross A., Richard P.
Productive Machines 🇬🇧 Seed · Sep 2026 First-cheque stage site ↗

Digital-twin software optimising CNC machining feed rates and spindle speeds to eliminate chatter. Sheffield/Rotherham, UK.

Founders: Erdem O., Huseyin C.
HALO X-ray Technologies 🇬🇧 Funding round (follow-on) · Aug 2026 announcement ↗

X-ray detection/security screening technology company; round led by Agilent, with UKI2S and MEIF following on.

Silicon Microgravity (SMG) 🇬🇧 Funding round · Jul 2026 · £6M announcement ↗

UK MEMS semiconductor manufacturer for defence, space and sensing applications; West Hill Capital led.

Revolver Therapeutics Funding round (follow-on) · Jul 2026 · £572K announcement ↗

Peptide therapies targeting 'undruggable' cancer transcription factors; led by QantX with UKI2S and University of Bath following on.

Founders: Mark T.
Luffy AI 🇬🇧 Series A · Jul 2026 site ↗

Neuroplastic AI for real-time adaptive control of robots, motors and automotive systems using sparse neural networks. Abingdon, UK.

Founders: Matthew C., Alex M., Phil L.

03 · Similar firms

Raising? See which European funds fit your round →